Introduction:
The global market for rosuvastatin, a popular cholesterol-lowering drug also known as Crestor, has been steadily growing in recent years. According to recent statistics, the demand for rosuvastatin is expected to increase by 5% annually over the next five years. In Israel, the pharmaceutical industry has been thriving, with several manufacturers producing high-quality generic versions of rosuvastatin. In this report, we will highlight the top 10 rosuvastatin (Crestor) generic manufacturers in Israel.
Top 10 Rosuvastatin (Crestor) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is the largest pharmaceutical company in Israel and one of the top generic manufacturers of rosuvastatin. With a production volume of over 1,000 kilograms per year, Teva holds a significant market share in the country.
2. Perrigo Company plc
Perrigo Company plc is another key player in the Israeli pharmaceutical industry, specializing in the production of generic rosuvastatin. Perrigo’s rosuvastatin products are known for their high quality and competitive pricing, making them a popular choice among consumers.
3. Mylan N.V.
Mylan N.V. is a global pharmaceutical company with a strong presence in Israel. The company produces a substantial amount of generic rosuvastatin each year, contributing to the country’s growing pharmaceutical industry.
4. Sandoz International GmbH
Sandoz International GmbH, a subsidiary of Novartis, is a leading manufacturer of generic rosuvastatin in Israel. The company’s products are widely used in the country’s healthcare system, helping to meet the growing demand for cholesterol-lowering medications.
5. Rafa Laboratories Ltd.
Rafa Laboratories Ltd. is a well-established pharmaceutical company in Israel, known for its high-quality generic medications. The company’s rosuvastatin products have gained popularity among healthcare providers and patients alike, driving its success in the market.
6. Taro Pharmaceuticals Industries Ltd.
Taro Pharmaceuticals Industries Ltd. is a prominent player in the Israeli pharmaceutical industry, producing a significant amount of generic rosuvastatin each year. The company’s commitment to quality and innovation has helped it maintain a strong position in the market.
7. Neopharm Group
Neopharm Group is a leading distributor of pharmaceutical products in Israel, including generic rosuvastatin. The company works closely with manufacturers to ensure a steady supply of high-quality medications to meet the country’s healthcare needs.
8. Dexcel Pharma
Dexcel Pharma is a reputable pharmaceutical company in Israel, specializing in the production of generic rosuvastatin. The company’s products are widely used in the country’s healthcare system, contributing to its strong market presence.
9. CTS Group
CTS Group is a well-known pharmaceutical company in Israel, producing a range of generic medications, including rosuvastatin. The company’s commitment to quality and affordability has helped it gain a loyal customer base in the country.
10. Biopharm
Biopharm is a key player in the Israeli pharmaceutical industry, manufacturing generic rosuvastatin for the local market. The company’s focus on research and development has allowed it to stay competitive in the ever-evolving pharmaceutical landscape.
Insights:
The market for rosuvastatin generic manufacturers in Israel is expected to continue growing in the coming years, driven by the increasing prevalence of cardiovascular diseases and the rising demand for cholesterol-lowering medications. With advancements in technology and research, manufacturers are likely to introduce new and improved formulations of rosuvastatin to meet the evolving needs of patients. Additionally, the growing emphasis on preventive healthcare and the rising awareness of the importance of managing cholesterol levels are expected to further boost the demand for rosuvastatin in Israel. As the market continues to expand, manufacturers will need to focus on innovation and quality to stay ahead of the competition and meet the growing needs of healthcare providers and patients.
Related Analysis: View Previous Industry Report
